tiprankstipranks
Trending News
More News >
Xilio Therapeutics Inc (XLO)
:XLO
US Market
Advertisement

Xilio Therapeutics (XLO) Ownership - Who Owns Xilio Therapeutics?

Compare
188 Followers

Xilio Therapeutics (XLO) Ownership Overview

18.26%2.93%1.29%2.22%75.30%
18.26% Insiders
1.29% Other Institutional Investors
2.22% ETFs
75.30% Public Companies and Individual Investors
The ownership structure of Xilio Therapeutics (XLO) stock is a mix of institutional, retail, and individual investors. Approximately 6.44% of the company’s stock is owned by Institutional Investors, 18.26% is owned by Insiders, and 75.30% is owned by Public Companies and Individual Investors.
The ownership structure of Xilio Therapeutics (XLO) stock is a mix of institutional, retail, and individual investors. Approximately 4.22% of the company’s stock is owned by Institutional Investors, 18.26% is owned by Insiders, and 2.22% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 18, 2025
xxxxxxxxxxxxx
$24677
Jun 18, 2025
xxxxxxxxxxxxx
$47600
Dec 19, 2024
xxxxxxxxxxxxx
$1830377

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,105,451Insider17.58%6,492,187
1,148,079Institution2.22%818,580
1,132,772Institution2.19%807,666
311,639Institution0.60%222,199
281,172Insider0.54%200,476
71,081Institution0.14%50,681
70,000Insider0.14%49,910
1,107Institution<0.01%789

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,132,772Institution2.19%807,666
311,639Institution0.60%222,199
71,081Institution0.14%50,681
1,107Institution<0.01%789

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
739,563Institution1.43%791,332
408,516Institution0.79%437,112

FAQ

Who Owns Xilio Therapeutics Inc (XLO)?
According to the latest TipRanks data, approximately 1.29% of the company's stock is held by institutional investors, 18.26% is held by insiders, and 75.30% is held by retail investors.
    What percentage of Xilio Therapeutics Inc (XLO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.29% of Xilio Therapeutics Inc (XLO) stock is held by institutional investors.
      What percentage of Xilio Therapeutics Inc (XLO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 75.30% of Xilio Therapeutics Inc (XLO) stock is held by retail investors.
        Who owns the most shares of Xilio Therapeutics Inc (XLO)?
        Gilead Sciences Inc owns the most shares of Xilio Therapeutics Inc (XLO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis